全文获取类型
收费全文 | 635篇 |
免费 | 39篇 |
国内免费 | 30篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 29篇 |
妇产科学 | 15篇 |
基础医学 | 44篇 |
口腔科学 | 12篇 |
临床医学 | 76篇 |
内科学 | 122篇 |
皮肤病学 | 17篇 |
神经病学 | 17篇 |
特种医学 | 57篇 |
外科学 | 100篇 |
综合类 | 59篇 |
预防医学 | 26篇 |
眼科学 | 3篇 |
药学 | 36篇 |
肿瘤学 | 89篇 |
出版年
2023年 | 1篇 |
2022年 | 2篇 |
2021年 | 14篇 |
2020年 | 5篇 |
2019年 | 10篇 |
2018年 | 17篇 |
2017年 | 3篇 |
2016年 | 13篇 |
2015年 | 12篇 |
2014年 | 24篇 |
2013年 | 33篇 |
2012年 | 38篇 |
2011年 | 32篇 |
2010年 | 27篇 |
2009年 | 19篇 |
2008年 | 25篇 |
2007年 | 31篇 |
2006年 | 34篇 |
2005年 | 39篇 |
2004年 | 22篇 |
2003年 | 19篇 |
2002年 | 22篇 |
2001年 | 11篇 |
2000年 | 11篇 |
1999年 | 13篇 |
1998年 | 31篇 |
1997年 | 35篇 |
1996年 | 30篇 |
1995年 | 19篇 |
1994年 | 13篇 |
1993年 | 19篇 |
1992年 | 5篇 |
1991年 | 1篇 |
1990年 | 4篇 |
1989年 | 12篇 |
1988年 | 5篇 |
1987年 | 7篇 |
1986年 | 3篇 |
1985年 | 14篇 |
1984年 | 3篇 |
1983年 | 4篇 |
1982年 | 5篇 |
1981年 | 6篇 |
1980年 | 1篇 |
1978年 | 4篇 |
1977年 | 2篇 |
1975年 | 3篇 |
1970年 | 1篇 |
排序方式: 共有704条查询结果,搜索用时 15 毫秒
91.
SP Cannavò† F Borgia† M Vaccaro† F Guarneri† E Magliolo‡ B Guarneri† 《Journal of the European Academy of Dermatology and Venereology》2002,16(6):625-627
Pretibial myxoedema is a cutaneous mucinosis typically associated with Graves' disease, although it may also develop in subjects with non-thyrotoxic thyroid pathologies. This report presents a rare case of pretibial myxoedema occurring in a 58-year-old woman with biopsy-proven Hashimoto's thyroiditis. The hypothetical pathogenetic link between the two disorders is discussed with particular attention to the role of thyroid stimulating hormone receptor antibodies. 相似文献
92.
93.
The molecular lesions causing beta-thalassemia in Sicily can be subdivided into two groups. One that occurs at a 71% frequency and consists of the beta 39, IVS 1,110 and IVS 1,6 mutations and the other group at a 20% frequency comprising the -87, beta s, IVS 1,1 and IVS 2,745 mutations. The identification of all these mutations by polymerase chain reaction (PCR) and conventional dot-blot hybridization has been time consuming and expensive. In this article, we describe the implementation of the reverse dot-blot (RDB) hybridization as a rapid nonradioactive method for the identification of the nine most frequent molecular lesions in the beta-globin gene (-87, beta s, beta c, IVS 1,1, IVS 1,6, IVS 1,110, beta 39, IVS 2,1, IVS 2,745) in Sicily. Sixty prenatal diagnoses were performed by this RDB assay, each of which was confirmed by dot-blot/ASO hybridization; thus demonstrating the accuracy of the RDB. The main advantage of this assay is the rapid typing of an individual's DNA for many mutations in a single working day. Because the mutations in this assay are representative for the Mediterranean region, this mutational panel can also be extended to the screening of beta-thalassemia from other Mediterranean regions. 相似文献
94.
95.
Inhibition of tissue factor/factor VIIa activity in plasma requires factor X and an additional plasma component 总被引:10,自引:0,他引:10
A study was carried out to explore requirements for the inhibition of tissue factor-factor VIIa enzymatic activity in plasma. Reaction mixtures contained plasma, 3H-factor IX or 3H-factor X, tissue factor (vol/vol 2.4% to 24%), and calcium. Tissue factor-factor VIIa activity was evaluated from progress curves of activation of factor IX or factor X, plotted from tritiated activation peptide release data. With normal plasma, progress curves exhibited initial limited activation followed by a plateau indicative of loss of tissue factor-factor VIIa activity. With hereditary factor X-deficient plasma treated with factor X antibodies, progress curves revealed full factor IX activation. Adding only 0.4 micrograms/mL factor X (final concentration) could restore inhibition. Inhibition was not observed in purified systems containing 6% to 24% tissue factor, factor VII, 0.5 micrograms/mL, factor IX, 13 micrograms/mL, and factor X up to 0.8 micrograms/mL, but could be induced by adding barium-absorbed plasma to the reaction mixture. Thus, both factor X and an additional material in plasma were required for inhibition. The amount of factor X needed appeared related to the concentration of tissue factor; adding more tissue factor at the plateau of a progress curve induced further activation. These results also indicate that inhibited reaction mixtures contained active free factor VII(a). Preliminary data suggest that inhibition may stem from loss of activity of the tissue factor component of the tissue factor- factor VII(a) complex. 相似文献
96.
97.
98.
99.
Persistent primitive sciatic artery 总被引:1,自引:0,他引:1
100.
Efstathiou JA Zietman AL Kaufman DS Heney NM Coen JJ Shipley WU 《World journal of urology》2006,24(5):517-529
Although immediate radical cystectomy remains the standard of care for invasive bladder cancer, a large body of international experience from single institutions and cooperative groups has accumulated, suggesting favorable results with bladder-sparing approaches in appropriately selected patients. Modern selective bladder preservation with trimodality therapy, consisting of transurethral resection of the bladder tumor, radiation, and chemotherapy, can achieve complete response rates of 60–80%, 5-year survival rates of 50–60%, and survival rates with an intact bladder of 40–45%. Although no randomized comparisons between cystectomy and trimodality therapy exist, long-term data confirm that the 10-year overall and disease-specific survival rates for patients in bladder-sparing protocols are comparable to outcomes reported in contemporary cystectomy series. In addition, quality of life studies have demonstrated that the retained native bladder functions well. Thus, trimodality therapy with careful cystoscopic surveillance and with prompt cystectomy for invasive recurrences has emerged as a legitimate alternative to extirpative surgery. Future work will continue to optimize the bladder-sparing regimen while limiting toxicity. 相似文献